Stent Angioplasty for Cervical Carotid Artery Stenosis in High-Risk Symptomatic NASCET-Ineligible Patients

Background and Purpose Although the North American Symptomatic Carotid Endarterectomy Trial (NASCET) has shown carotid endarterectomy (CEA) to be protective compared with medical therapy alone, its stringent eligibility criteria excluded patients with severe medical, angiographic, and neurological risk factors. We sought to determine the safety and efficacy of stent angioplasty in this high-risk subset for whom the perioperative morbidity and mortality of surgery are elevated. Methods Twenty-eight consecutive symptomatic NASCET-ineligible patients (10 female; median age, 72.2 years) underwent microcatheter-based carotid stent angioplasty. Half of the patients had sustained a previous stroke. Classification of surgical risk by Sundt criteria yielded no patients in grade 1, 3 patients in grade 2 (10.7%), 8 in grade 3 (28.6%), and 17 (60.7%) in grade 4. Stratification of stroke risk for medical therapy according to the European Carotid Surgery Trial (ECST) 5-point score showed 8 patients with a score of 3 (28.6%), 12 with 4 (42.8%), and 8 with 5 (28.6%). Follow-up was obtained in all patients at a median of 14 months. Results The procedure was technically successful in all cases (100%), with immediate stenosis reduction from a mean of 80.3% to 2.7%. There were no periprocedural deaths, 1 major stroke (3.6%), no minor strokes, and 3 transient ischemic attacks (10.7%). In-hospital complications included 2 nonfatal myocardial infarctions, 1 case of acute renal failure, and 1 groin hematoma requiring transfusion. There were 5 deaths during the follow-up period, all beyond 30 days after the procedure: 3 from cardiac causes, 1 from lung cancer, and 1 following unrelated surgery. The patient with major stroke died at 7.8 months during rehabilitation. No surviving patients had further strokes, and all except 1 (95.5%) remained asymptomatic. Anatomic follow-up in 20 patients showed occlusion in 2 (10%) (1 symptomatic, 1 asymptomatic) and intimal hyperplasia in 3 asymptomatic patients (15%). Conclusions The clinical results and sustained freedom from symptoms and stroke during the short available follow-up period suggest that stent angioplasty may be useful in the treatment of symptomatic cervical carotid stenosis in high-risk patients despite a notable incidence of restenosis.

[1]  D. Sackett,et al.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.

[2]  D B Matchar,et al.  Predicting Complications of Carotid Endarterectomy , 1993, Stroke.

[3]  D. Long,et al.  Preoperative risks predict neurological outcome of carotid endarterectomy related stroke , 1992 .

[4]  S S Iyer,et al.  Predictors of stroke complicating carotid artery stenting. , 1998, Circulation.

[5]  Gary G. Ferguson,et al.  Medical Complications Associated With Carotid Endarterectomy , 1999 .

[6]  W S Moore,et al.  Recurrent carotid stenosis : results of the asymptomatic carotid atherosclerosis study. , 1998, Stroke.

[7]  P. Gorelick,et al.  Carotid endarterectomy. Where do we draw the line? , 2000, Gefässchirurgie.

[8]  S. Davis,et al.  Surgery for prevention of stroke , 1998, The Lancet.

[9]  R. Hobson,et al.  Carotid restenosis: long-term noninvasive follow-up after carotid endarterectomy. , 1987, Stroke.

[10]  T. Sundt,et al.  Carotid endarterectomy. Complications and preoperative assessment of risk. , 1975, Mayo Clinic proceedings.

[11]  Max Amor,et al.  Angioplasty and Stenting of the Extracranial Carotid Arteries , 1998, Texas Heart Institute journal.

[12]  T. Sundt,et al.  Prospective study of the effectiveness and durability of carotid endarterectomy. , 1990, Mayo Clinic proceedings.

[13]  A. Fox,et al.  Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. The North American Symptomatic Carotid Endarterectomy Trail. , 1999, Stroke.

[14]  G. Roubin,et al.  Angioplasty and stenting for restenosis after carotid endarterectomy. Initial experience. , 1996, Stroke.

[15]  V. Hachinski,et al.  The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. , 1999, Stroke.

[16]  Edward B. Diethrich,et al.  Stenting in the Carotid Artery: Initial Experience in 110 Patients , 1996, Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery.

[17]  K. Schimrigk,et al.  Microembolic signals and intraoperative stroke in carotid endarterectomy , 1998, Acta neurologica Scandinavica.

[18]  L. Guimaraens,et al.  Carotid artery stenosis: treatment with protected balloon angioplasty and stent placement. , 1996, Radiology.

[19]  W. Jordan,et al.  Elective stenting of the extracranial carotid arteries. , 1997, Circulation.

[20]  J. Slattery,et al.  A systematic comparison of the risks of stroke and death due to carotid endarterectomy for symptomatic and asymptomatic stenosis. , 1996, Stroke.

[21]  P. Gorelick,et al.  Carotid endarterectomy : where do we draw the line? , 1999, Stroke.

[22]  M Henry,et al.  Current global status of carotid artery stent placement. , 1998, Catheterization and cardiovascular diagnosis.

[23]  C. Warlow,et al.  Prediction of benefit from carotid endar terectomy in individual patients: a risk-modelling study , 1999, The Lancet.

[24]  D. Long,et al.  Preoperative risks predict neurological outcome of carotid endarterectomy related stroke. , 1993, Neurosurgery.

[25]  J. Slattery,et al.  Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) , 1998, The Lancet.

[26]  U Kaul,et al.  Elective stenting of extracranial carotid arteries. , 1997, The Journal of the Association of Physicians of India.

[27]  B. Brener Prospective study of the effectiveness and durability of carotid endarterectomy: Sundt TM, Whisnant JP, Houser OW, Fode NC. Mayo Clin Proc 1990; 65: 625-35 , 1991 .